Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteers

NCT ID: NCT06488326

Last Updated: 2024-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-02-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Volunteers will be divided into 4 groups which are mulberry leaf extract 6 mg capsule, mulberry leaf extract 12 mg capsule, mulberry leaf extract 18 mg capsule, and placebo capsule group. They will be tested blood glucose levels (taken from the fingertips) before starting. Then, they will take 1 capsule of the sample one time. After taking the sample for 30 minutes, they will take 50 g of sucrose in 250 ml of water in 5 minutes. Then, they will be tested blood glucose levels (taken from the fingertips) at 30, 60, 90, and 120 minutes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health, Subjective

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mulberry leaf extract 6 mg capsule

Take one capsule of the sample one time.

Group Type EXPERIMENTAL

Mulberry leaf extract 6 mg capsule

Intervention Type DRUG

Take one capsule of the sample one time.

Mulberry leaf extract 12 mg capsule

Take one capsule of the sample one time.

Group Type EXPERIMENTAL

Mulberry leaf extract 12 mg capsule

Intervention Type DRUG

Take one capsule of the sample one time.

Mulberry leaf extract 18 mg capsule

Take one capsule of the sample one time.

Group Type EXPERIMENTAL

Mulberry leaf extract 18 mg capsule

Intervention Type DRUG

Take one capsule of the sample one time.

Placebo capsule

Take one capsule of the sample one time.

Group Type PLACEBO_COMPARATOR

Placebo capsule

Intervention Type DRUG

Take one capsule of the sample one time.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mulberry leaf extract 6 mg capsule

Take one capsule of the sample one time.

Intervention Type DRUG

Mulberry leaf extract 12 mg capsule

Take one capsule of the sample one time.

Intervention Type DRUG

Mulberry leaf extract 18 mg capsule

Take one capsule of the sample one time.

Intervention Type DRUG

Placebo capsule

Take one capsule of the sample one time.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-60 years
* No diabetes mellitus
* Have blood glucose less than 126 mg/dL
* Wiling to attend the study

Exclusion Criteria

* Take steroids, psychiatric medicine, thiazide diuretic medicine, and beta blocker medicine within 2 weeks before starting of the study
* Take dietary supplement, herbal substance, and weight-loss medicine within 2 weeks before starting of the study
* Uncontrolled diseases
* History of gastrointestinal tract surgery
* Liver and Kidney diseases
* Pregnancy and lactation
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mae Fah Luang University

OTHER

Sponsor Role collaborator

Chulalongkorn University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pornanong Aramwit, Pharm.D., Ph.D

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC23188-20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gum Acacia and Blood Glucose
NCT03716479 COMPLETED NA